
Henan Taloph Pharmaceutical Stock Co.,Ltd
SSE:600222.SS
5.87 (CNY) • At close June 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 1,941.42 | 2,069.909 | 1,960.694 | 1,604.517 | 1,417.097 | 1,311.815 | 1,194.794 | 1,168.391 | 953.307 | 1,017.381 | 1,254.23 | 1,304.675 | 1,089.131 | 980.782 | 913.303 | 813.144 | 612.738 | 371.161 | 364.543 | 251.323 | 204.04 | 170.449 | 181.813 | 136.082 | 139.923 | 167.561 | 136.718 | 155.73 | 98.28 |
Cost of Revenue
| 1,444.561 | 1,505.186 | 1,488.614 | 1,141.45 | 1,042.225 | 827.453 | 792.644 | 812.927 | 645.849 | 774.582 | 1,004.772 | 1,051.377 | 906.112 | 855.039 | 798.204 | 701.194 | 517.08 | 290.533 | 286.903 | 173.186 | 128.186 | 84.775 | 92.586 | 62.76 | 54.129 | 77.678 | 57.712 | 57.881 | 35.38 |
Gross Profit
| 496.859 | 564.722 | 472.081 | 463.067 | 374.872 | 484.362 | 402.15 | 355.464 | 307.458 | 242.798 | 249.458 | 253.298 | 183.018 | 125.742 | 115.099 | 111.949 | 95.657 | 80.628 | 77.64 | 78.137 | 75.854 | 85.673 | 89.228 | 73.322 | 85.793 | 89.883 | 79.006 | 97.85 | 62.9 |
Gross Profit Ratio
| 0.256 | 0.273 | 0.241 | 0.289 | 0.265 | 0.369 | 0.337 | 0.304 | 0.323 | 0.239 | 0.199 | 0.194 | 0.168 | 0.128 | 0.126 | 0.138 | 0.156 | 0.217 | 0.213 | 0.311 | 0.372 | 0.503 | 0.491 | 0.539 | 0.613 | 0.536 | 0.578 | 0.628 | 0.64 |
Reseach & Development Expenses
| 100.891 | 127.714 | 116.52 | 56.496 | 63.665 | 59.386 | 58.117 | 40.649 | 41.271 | 8.29 | 0.782 | 0.797 | 0.004 | 0.003 | 0.658 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 34.212 | 46.401 | 46.827 | 39.819 | 38.98 | 36.633 | 30.367 | 22.776 | 35.058 | 23.742 | 16.404 | 12.797 | 12.482 | 9.216 | 10.699 | 33.5 | 30.873 | 23.057 | 26.385 | 27.83 | 22.554 | 22.22 | 25.918 | 16.189 | 12.791 | 11.593 | 9.942 | 11.224 | 11.89 |
Selling & Marketing Expenses
| 109.626 | 140.46 | 183.025 | 131.277 | 102.259 | 176.978 | 137.069 | 115.652 | 76.616 | 71.864 | 72.622 | 74.506 | 56.377 | 42.166 | 37.327 | 26.994 | 23.917 | 20.171 | 21.996 | 19.167 | 23.818 | 43.617 | 38.546 | 17.216 | 21.4 | 24.628 | 12.068 | 21.367 | 13.453 |
SG&A
| 143.838 | 351.354 | 229.852 | 171.095 | 141.239 | 213.611 | 167.437 | 138.427 | 111.674 | 95.606 | 89.026 | 87.303 | 68.859 | 51.382 | 48.026 | 60.494 | 54.79 | 43.228 | 48.381 | 46.997 | 46.371 | 65.837 | 64.464 | 33.404 | 34.191 | 36.221 | 22.01 | 32.591 | 25.343 |
Other Expenses
| 216.411 | 38.311 | 83.084 | 78.381 | 57.556 | 75.963 | -2.229 | -11.355 | 3.736 | 2.296 | 0.979 | 46.176 | 5.776 | 13.337 | 7.481 | 6.103 | 7.816 | 1.732 | 13.607 | 10.683 | 7.939 | 9.044 | -0.156 | -0.3 | 9.637 | -0.331 | -1.206 | 7.124 | 1.519 |
Operating Expenses
| 461.139 | 517.38 | 429.456 | 305.973 | 262.46 | 348.959 | 318.752 | 266.997 | 233.738 | 189.489 | 142.021 | 145.113 | 113.656 | 85.505 | 76.506 | 62.809 | 56.785 | 45.259 | 49.976 | 47.775 | 47.829 | 67.711 | 66.45 | 35.075 | 35.713 | 37.492 | 23.029 | 33.946 | 26.555 |
Operating Income
| 35.719 | 44.167 | 27.464 | 130.771 | 119.94 | 139.555 | -113.111 | 21.857 | 7.356 | -8.557 | 64.206 | 63.614 | 35.432 | 14.189 | 27.274 | 31.366 | 18.667 | 24.501 | 15.219 | 19.645 | 19.341 | 7.578 | 15.182 | 33.51 | 45.485 | 45.648 | 39.602 | 37.153 | 14.743 |
Operating Income Ratio
| 0.018 | 0.021 | 0.014 | 0.082 | 0.085 | 0.106 | -0.095 | 0.019 | 0.008 | -0.008 | 0.051 | 0.049 | 0.033 | 0.014 | 0.03 | 0.039 | 0.03 | 0.066 | 0.042 | 0.078 | 0.095 | 0.044 | 0.084 | 0.246 | 0.325 | 0.272 | 0.29 | 0.239 | 0.15 |
Total Other Income Expenses Net
| -0.645 | -1.204 | -110.313 | -28.158 | -90.7 | -91.719 | -189.08 | -11.355 | 3.056 | 1.401 | 0.971 | 3.375 | -28.972 | -11.696 | -4.924 | -9.251 | -10.084 | -9.135 | -10.019 | -10.76 | -9.445 | 9.035 | -0.161 | -0.354 | 2.711 | -0.331 | -1.706 | 7.124 | 1.519 |
Income Before Tax
| 35.074 | 42.962 | -82.849 | 7.45 | 29.24 | 51.234 | -115.341 | 10.502 | 10.412 | -7.157 | 65.177 | 66.989 | 41.175 | 27.526 | 34.754 | 37.452 | 26.422 | 26.233 | 16.211 | 19.605 | 18.585 | 16.613 | 15.021 | 33.156 | 50.822 | 45.317 | 37.896 | 44.276 | 16.262 |
Income Before Tax Ratio
| 0.018 | 0.021 | -0.042 | 0.005 | 0.021 | 0.039 | -0.097 | 0.009 | 0.011 | -0.007 | 0.052 | 0.051 | 0.038 | 0.028 | 0.038 | 0.046 | 0.043 | 0.071 | 0.044 | 0.078 | 0.091 | 0.097 | 0.083 | 0.244 | 0.363 | 0.27 | 0.277 | 0.284 | 0.165 |
Income Tax Expense
| -18.421 | -1.867 | -7.133 | 0.671 | 1.644 | 6.269 | 0.117 | 3.134 | 8.559 | -11.562 | 15.004 | 15.285 | 9.139 | 6.639 | 6.931 | 5.892 | 2.328 | 4.926 | 1.588 | 3.594 | 3.802 | 4.728 | 4.3 | 4.157 | 7.948 | 6.876 | 5.708 | 6.871 | 1.622 |
Net Income
| 50.525 | 43.557 | -75.716 | 5.995 | 29.241 | 45.712 | -115.318 | 5.127 | 4.016 | 5.557 | 32.035 | 36.06 | 20.199 | 12.751 | 24.272 | 30.147 | 23.168 | 20.693 | 18.036 | 17.044 | 16.248 | 14.772 | 10.914 | 29.086 | 42.874 | 38.441 | 32.188 | 37.406 | 14.641 |
Net Income Ratio
| 0.026 | 0.021 | -0.039 | 0.004 | 0.021 | 0.035 | -0.097 | 0.004 | 0.004 | 0.005 | 0.026 | 0.028 | 0.019 | 0.013 | 0.027 | 0.037 | 0.038 | 0.056 | 0.049 | 0.068 | 0.08 | 0.087 | 0.06 | 0.214 | 0.306 | 0.229 | 0.235 | 0.24 | 0.149 |
EPS
| 0.091 | 0.077 | -0.13 | 0.011 | 0.054 | 0.08 | -0.2 | 0.009 | 0.007 | 0.01 | 0.065 | 0.081 | 0.049 | 0.031 | 0.059 | 0.073 | 0.056 | 0.05 | 0.032 | 0.032 | 0.03 | 0.027 | 0.02 | 0.054 | 0.075 | 0.071 | 0.078 | 0.091 | 0.036 |
EPS Diluted
| 0.091 | 0.077 | -0.13 | 0.011 | 0.054 | 0.08 | -0.2 | 0.009 | 0.007 | 0.01 | 0.065 | 0.081 | 0.049 | 0.031 | 0.059 | 0.073 | 0.056 | 0.05 | 0.032 | 0.032 | 0.03 | 0.027 | 0.02 | 0.054 | 0.075 | 0.071 | 0.078 | 0.091 | 0.036 |
EBITDA
| 102.514 | 111.808 | 90.448 | 187.956 | 142.461 | 98.65 | 141.389 | 67.877 | 63.88 | 43.637 | 108.03 | 108.878 | 77.883 | 57.741 | 61.071 | 70.474 | 58.29 | 54.03 | 43.969 | 46.113 | 43.198 | 38.608 | 36.665 | 48.711 | 59.24 | 56.112 | 56.656 | 63.903 | 36.345 |
EBITDA Ratio
| 0.053 | 0.054 | 0.046 | 0.117 | 0.101 | 0.075 | 0.118 | 0.058 | 0.067 | 0.043 | 0.086 | 0.083 | 0.072 | 0.059 | 0.067 | 0.087 | 0.095 | 0.146 | 0.121 | 0.183 | 0.212 | 0.227 | 0.202 | 0.358 | 0.423 | 0.335 | 0.414 | 0.41 | 0.37 |